CGL
AGN

Clarius Group LLC’s Allergan plc AGN Stock Holding History

Clarius Group LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,036
Closed -$361K – 300
2020
Q1 		$361K Buy
2,036
+293
+17% +$55.2K 0.07% 153
2019
Q4 		$338K Buy
1,743
+195
+13% +$35.2K 0.05% 187
2019
Q3 		$261K Buy
+1,548
New +$252K 0.05% 216

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Clarius Group LLC's AGN Position: Q2 2020 in Review

Clarius Group LLC sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,036 shares — an estimated $361K sold.

Clarius Group LLC first reported a position in AGN in Q3 2019 and held it in 3 quarters. The position peaked at $361K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Clarius Group LLC reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Clarius Group LLC sold 2,036 Allergan plc shares in Q2 2020, an estimated $361K.
  • Clarius Group LLC first reported a position in Allergan plc in Q3 2019 and held it in 3 quarters.
  • Clarius Group LLC's Allergan plc position peaked at $361K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Clarius Group LLC's 13F filing for Q2 2020, filed 8 Jul 2020.